Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals

Trials

Volumn 17, Issue 1, 2016, Pages

  Downing, Nicholas S ^a   Shah, Nilay D ^b   Neiman, Joseph H ^c   Aminawung, Jenerius A ^d   Krumholz, Harlan M ^a,d,e   Ross, Joseph S ^a,d,e  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNICITY; EVIDENCE BASED MEDICINE; FEMALE; FOOD AND DRUG ADMINISTRATION; GENDER; HUMAN; MALE; MINORITY GROUP; PATIENT SAFETY; RACE; SOCIAL PARTICIPATION; UNITED STATES; ADULT; AGE; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; ETHNIC GROUP; FACTUAL DATABASE; HEALTH CARE DISPARITY; HEALTH DISPARITY; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; SEX FACTOR; TIME FACTOR;

ADULT; AGE FACTORS; AGED; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG APPROVAL; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; PATIENT SELECTION; SEX FACTORS; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84963502461     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1322-4     Document Type: Article

References (20)

1. Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA. 2014;311(4):368-77.
2. Gifford AL, Cunningham WE, Heslin KC, Andersen RM, Nakazono T, Lieu DK, et al. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002;346(18):1373-82.
3. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2000;343(7):475-80.
4. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162(15):1682-8.
5. Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061-7.
6. Kim ESH, Carrigan TP, Menon V. Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol. 2008;52(8):672-3.
7. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001;286(6):708-13.
8. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720-6.
9. U.S. Food and Drug Administration. Investigational new drug applications and new drug applications. 21 CFR 312, 63 FR 6854. 11 Feb 1998. http://www.gpo.gov/fdsys/granule/FR-1998-02-11/98-3422. Accessed 6 Apr 2016.
10. U.S. Food and Drug Administration (FDA). Collection, analysis, and availability of demographic subgroup data for FDA-approved medical products. FDA report. Silver Spring, MD: FDA; August 2013. http://www.fda.gov/downloads/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/UCM365544.pdf. Accessed 6 Apr 2016.
11. Eshera N, Itana H, Zhang L, Soon G, Fadiran EO. Demographics of clinical trials participants in pivotal clinical trials for new molecular entity drugs and biologics approved by FDA from 2010 to 2012. Am J Ther. 2015;22(6):435-55. doi: 10.1097/MJT.0000000000000177.
12. U.S. Food and Drug Administration. Drugs@FDA. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. Accessed 6 Apr 2016.
13. U.S. Food and Drug Administration. Search orphan drug designations and approvals. http://www.accessdata.fda.gov/scripts/opdlisting/oopd/. Accessed 6 Apr 2016.
14. U.S. Census Bureau. American FactFinder. DP-1-Geography-United States: profile of general population and housing characteristics: 2010. http://factfinder.census.gov/faces/nav/jsf/pages/index.xhtml. Accessed 6 Apr 2016.
15. Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, Pieper KS, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3(2):135-42.
16. National Cancer Institute, Surveillance, Epidemiology, and End Results Program (SEER). SEER cancer statistics review 1975-2012: Table 2.7. Incidence and mortality rates by age. http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=2&pageSEL=sect_02_table.07.html. Accessed 6 Apr 2016.
17. Smedley BD, Stith AY, Nelson AR, editors. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: The National Academies Press; 2003.
18. U.S. Food and Drug Administration. Guidance for industry: collection of race and ethnicity data in clinical trials. Washington, DC: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiologic Health (CDRH), Office of the Commissioner (OC); September 2005. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126396.pdf. Accessed 6 Apr 2016.
19. U.S. Food and Drug Administration (FDA). FDA action plan to enhance the collection and availability of demographic subgroup data. FDA report. Silver Spring, MD: FDA; August 2014. http://www.fda.gov/downloads/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/UCM410474.pdf. Accessed 6 Apr 2016.
20. U.S. Food and Drug Administration. Drug trials snapshots. http://www.fda.gov/Drugs/InformationOnDrugs/ucm412998.htm. Accessed 6 Apr 2016.